25 XP   0   0   10

Shandong Realcan Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Realcan together

PenkeI guess you are interested in Shandong Realcan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shandong Realcan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shandong Realcan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Realcan Pharmaceutical Co Ltd.

Quick analysis of Realcan (30 sec.)










What can you expect buying and holding a share of Realcan? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.79
Expected worth in 1 year
¥1.88
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
¥-1.62
Return On Investment
-53.4%

For what price can you sell your share?

Current Price per Share
¥3.03
Expected price per share
¥2.51 - ¥3.19
How sure are you?
50%

1. Valuation of Realcan (5 min.)




Live pricePrice per Share (EOD)

¥3.03

Intrinsic Value Per Share

¥5.67 - ¥6.77

Total Value Per Share

¥9.45 - ¥10.55

2. Growth of Realcan (5 min.)




Is Realcan growing?

Current yearPrevious yearGrowGrow %
How rich?$788.3m$1.2b-$498.7m-62.6%

How much money is Realcan making?

Current yearPrevious yearGrowGrow %
Making money-$64.8m$2.3m-$67.1m-103.6%
Net Profit Margin-33.2%0.4%--

How much money comes from the company's main activities?

3. Financial Health of Realcan (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#14 / 41

Most Revenue
#22 / 41

Most Profit
#40 / 41

What can you expect buying and holding a share of Realcan? (5 min.)

Welcome investor! Realcan's management wants to use your money to grow the business. In return you get a share of Realcan.

What can you expect buying and holding a share of Realcan?

First you should know what it really means to hold a share of Realcan. And how you can make/lose money.

Speculation

The Price per Share of Realcan is ¥3.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Realcan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Realcan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.79. Based on the TTM, the Book Value Change Per Share is ¥-0.48 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Realcan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.04-1.4%0.000.1%-0.01-0.4%0.000.0%
Usd Book Value Change Per Share-0.01-0.3%-0.07-2.2%-0.03-1.1%-0.03-0.9%0.010.4%
Usd Dividend Per Share0.010.3%0.010.3%0.010.4%0.010.5%0.010.4%
Usd Total Gains Per Share0.000.0%-0.06-1.8%-0.02-0.8%-0.01-0.4%0.020.7%
Usd Price Per Share0.49-0.52-0.59-0.73-2.09-
Price to Earnings Ratio-116.00-21.94-281.43-71.63-97.33-
Price-to-Total Gains Ratio10,595.22-2,678.52-66.78-574.03-395.18-
Price to Book Ratio0.93-0.98-0.68-0.84-6.45-
Price-to-Total Gains Ratio10,595.22-2,678.52-66.78-574.03-395.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.419352
Number of shares2384
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.07-0.03
Usd Total Gains Per Share-0.06-0.01
Gains per Quarter (2384 shares)-133.38-27.15
Gains per Year (2384 shares)-533.51-108.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
194-628-544137-246-119
2188-1255-1078275-492-228
3282-1883-1612412-738-337
4376-2510-2146550-984-446
5470-3138-2680687-1230-555
6564-3765-3214825-1476-664
7658-4393-3748962-1722-773
8752-5020-42821100-1968-882
9846-5648-48161237-2215-991
10940-6275-53501375-2461-1100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%35.05.00.087.5%46.05.00.090.2%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%10.010.00.050.0%30.010.00.075.0%41.010.00.080.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%51.00.00.0100.0%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%15.05.00.075.0%35.05.00.087.5%46.05.00.090.2%

Fundamentals of Realcan

About Shandong Realcan Pharmaceutical Co Ltd

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices. The company also provides medical logistics services; third-party logistics services; health service platform; and disinfection and sterilization. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.

Fundamental data was last updated by Penke on 2024-03-24 03:44:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Shandong Realcan Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Realcan earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • A Net Profit Margin of -0.6% means that ¥-0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is -0.6%. The company is not making a profit/loss.
  • The TTM is -33.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-33.2%+32.7%
TTM-33.2%YOY0.4%-33.7%
TTM-33.2%5Y-6.9%-26.4%
5Y-6.9%10Y-1.8%-5.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%1.9%-2.5%
TTM-33.2%2.2%-35.4%
YOY0.4%2.4%-2.0%
5Y-6.9%2.2%-9.1%
10Y-1.8%2.1%-3.9%
1.1.2. Return on Assets

Shows how efficient Realcan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • -0.1% Return on Assets means that Realcan generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-2.6%+2.5%
TTM-2.6%YOY0.1%-2.6%
TTM-2.6%5Y-0.6%-2.0%
5Y-0.6%10Y0.2%-0.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%0.8%-0.9%
TTM-2.6%0.9%-3.5%
YOY0.1%0.8%-0.7%
5Y-0.6%0.9%-1.5%
10Y0.2%1.0%-0.8%
1.1.3. Return on Equity

Shows how efficient Realcan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • -0.2% Return on Equity means Realcan generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-8.7%+8.5%
TTM-8.7%YOY0.2%-8.9%
TTM-8.7%5Y-2.2%-6.5%
5Y-2.2%10Y0.3%-2.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%2.1%-2.3%
TTM-8.7%2.5%-11.2%
YOY0.2%2.2%-2.0%
5Y-2.2%2.3%-4.5%
10Y0.3%2.4%-2.1%

1.2. Operating Efficiency of Shandong Realcan Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Realcan is operating .

  • Measures how much profit Realcan makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • An Operating Margin of 2.2% means the company generated ¥0.02  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 2.2%. The company is operating less efficient.
  • The TTM is -3.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ2.2%TTM-3.6%+5.7%
TTM-3.6%YOY4.0%-7.6%
TTM-3.6%5Y2.6%-6.1%
5Y2.6%10Y1.7%+0.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%3.1%-0.9%
TTM-3.6%2.6%-6.2%
YOY4.0%3.5%+0.5%
5Y2.6%3.3%-0.7%
10Y1.7%2.0%-0.3%
1.2.2. Operating Ratio

Measures how efficient Realcan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.84 means that the operating costs are ¥1.84 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 1.844. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.988. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.844TTM1.988-0.143
TTM1.988YOY1.790+0.198
TTM1.9885Y1.807+0.181
5Y1.80710Y1.377+0.430
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8441.369+0.475
TTM1.9881.369+0.619
YOY1.7901.413+0.377
5Y1.8071.312+0.495
10Y1.3771.210+0.167

1.3. Liquidity of Shandong Realcan Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Realcan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.05 means the company has ¥1.05 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 1.055. The company is just able to pay all its short-term debts.
  • The TTM is 1.049. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.055TTM1.049+0.005
TTM1.049YOY1.237-0.188
TTM1.0495Y1.233-0.184
5Y1.23310Y0.683+0.550
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0551.366-0.311
TTM1.0491.418-0.369
YOY1.2371.403-0.166
5Y1.2331.408-0.175
10Y0.6831.299-0.616
1.3.2. Quick Ratio

Measures if Realcan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • A Quick Ratio of 0.49 means the company can pay off ¥0.49 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 0.493. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.483. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.493TTM0.483+0.010
TTM0.483YOY0.762-0.279
TTM0.4835Y0.729-0.246
5Y0.72910Y0.861-0.132
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4930.758-0.265
TTM0.4830.757-0.274
YOY0.7620.828-0.066
5Y0.7290.814-0.085
10Y0.8610.850+0.011

1.4. Solvency of Shandong Realcan Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Realcan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Realcan to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.67 means that Realcan assets are financed with 67.3% credit (debt) and the remaining percentage (100% - 67.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 0.673. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.685. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.673TTM0.685-0.012
TTM0.685YOY0.638+0.047
TTM0.6855Y0.671+0.014
5Y0.67110Y0.644+0.027
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6730.617+0.056
TTM0.6850.606+0.079
YOY0.6380.608+0.030
5Y0.6710.610+0.061
10Y0.6440.593+0.051
1.4.2. Debt to Equity Ratio

Measures if Realcan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Realcan to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 213.9% means that company has ¥2.14 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The MRQ is 2.139. The company is just not able to pay all its debts with equity.
  • The TTM is 2.301. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.139TTM2.301-0.162
TTM2.301YOY2.249+0.052
TTM2.3015Y2.648-0.347
5Y2.64810Y2.243+0.405
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1391.698+0.441
TTM2.3011.678+0.623
YOY2.2491.752+0.497
5Y2.6481.733+0.915
10Y2.2431.738+0.505

2. Market Valuation of Shandong Realcan Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Realcan generates.

  • Above 15 is considered overpriced but always compare Realcan to the Medical Distribution industry mean.
  • A PE ratio of -116.00 means the investor is paying ¥-116.00 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The EOD is -99.572. Based on the earnings, the company is expensive. -2
  • The MRQ is -116.003. Based on the earnings, the company is expensive. -2
  • The TTM is 21.937. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-99.572MRQ-116.003+16.431
MRQ-116.003TTM21.937-137.940
TTM21.937YOY281.428-259.491
TTM21.9375Y71.627-49.691
5Y71.62710Y97.330-25.703
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-99.57213.475-113.047
MRQ-116.00314.623-130.626
TTM21.93718.845+3.092
YOY281.42818.249+263.179
5Y71.62717.230+54.397
10Y97.33019.682+77.648
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The EOD is 7.844. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.139. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.187. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.844MRQ9.139-1.294
MRQ9.139TTM13.187-4.048
TTM13.187YOY-26.033+39.220
TTM13.1875Y-36.243+49.430
5Y-36.24310Y-18.977-17.266
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD7.8446.313+1.531
MRQ9.1394.510+4.629
TTM13.1877.516+5.671
YOY-26.0335.255-31.288
5Y-36.2432.484-38.727
10Y-18.9771.762-20.739
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Realcan is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.93 means the investor is paying ¥0.93 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shandong Realcan Pharmaceutical Co Ltd:

  • The EOD is 0.800. Based on the equity, the company is cheap. +2
  • The MRQ is 0.933. Based on the equity, the company is cheap. +2
  • The TTM is 0.979. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.800MRQ0.933-0.132
MRQ0.933TTM0.979-0.047
TTM0.979YOY0.682+0.297
TTM0.9795Y0.841+0.138
5Y0.84110Y6.447-5.606
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.8001.110-0.310
MRQ0.9331.178-0.245
TTM0.9791.224-0.245
YOY0.6821.307-0.625
5Y0.8411.386-0.545
10Y6.4472.166+4.281
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shandong Realcan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.063-0.475+655%-0.250+297%-0.186+196%0.078-181%
Book Value Per Share--3.7853.826-1%6.221-39%6.313-40%5.004-24%
Current Ratio--1.0551.049+0%1.237-15%1.233-14%0.683+54%
Debt To Asset Ratio--0.6730.685-2%0.638+6%0.671+0%0.644+5%
Debt To Equity Ratio--2.1392.301-7%2.249-5%2.648-19%2.243-5%
Dividend Per Share--0.0630.071-11%0.081-22%0.104-39%0.085-26%
Eps---0.008-0.311+3992%0.011-169%-0.080+949%0.008-193%
Free Cash Flow Per Share--0.0970.0970%-0.065+167%0.073+32%0.107-10%
Free Cash Flow To Equity Per Share---0.223-0.229+2%0.005-4524%0.002-9328%0.013-1806%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.768--------
Intrinsic Value_10Y_min--5.669--------
Intrinsic Value_1Y_max--0.221--------
Intrinsic Value_1Y_min--0.217--------
Intrinsic Value_3Y_max--1.012--------
Intrinsic Value_3Y_min--0.959--------
Intrinsic Value_5Y_max--2.223--------
Intrinsic Value_5Y_min--2.034--------
Market Cap4559271348.480-17%5311627962.6305638902490.073-6%6372448844.685-17%7943365856.827-33%22753100932.396-77%
Net Profit Margin---0.006-0.332+5777%0.004-230%-0.069+1114%-0.018+223%
Operating Margin--0.022-0.036+267%0.040-46%0.026-16%0.017+25%
Operating Ratio--1.8441.988-7%1.790+3%1.807+2%1.377+34%
Pb Ratio0.800-17%0.9330.979-5%0.682+37%0.841+11%6.447-86%
Pe Ratio-99.572+14%-116.00321.937-629%281.428-141%71.627-262%97.330-219%
Price Per Share3.030-17%3.5303.748-6%4.235-17%5.279-33%15.121-77%
Price To Free Cash Flow Ratio7.844-17%9.13913.187-31%-26.033+385%-36.243+497%-18.977+308%
Price To Total Gains Ratio9094.480-17%10595.2192678.519+296%66.782+15765%574.033+1746%395.182+2581%
Quick Ratio--0.4930.483+2%0.762-35%0.729-32%0.861-43%
Return On Assets---0.001-0.026+3793%0.001-206%-0.006+818%0.002-137%
Return On Equity---0.002-0.087+4049%0.002-193%-0.022+942%0.003-166%
Total Gains Per Share--0.000-0.404+121433%-0.169+50774%-0.082+24798%0.163-100%
Usd Book Value--788330845.725796787210.708-1%1295531134.770-39%1314761143.965-40%1042127912.061-24%
Usd Book Value Change Per Share---0.009-0.066+655%-0.035+297%-0.026+196%0.011-181%
Usd Book Value Per Share--0.5240.530-1%0.861-39%0.874-40%0.693-24%
Usd Dividend Per Share--0.0090.010-11%0.011-22%0.014-39%0.012-26%
Usd Eps---0.001-0.043+3992%0.002-169%-0.011+949%0.001-193%
Usd Free Cash Flow--20110264.89120152293.8290%-13559985.806+167%15192963.656+32%12268742.483+64%
Usd Free Cash Flow Per Share--0.0130.0130%-0.009+167%0.010+32%0.015-10%
Usd Free Cash Flow To Equity Per Share---0.031-0.032+2%0.001-4524%0.000-9328%0.002-1806%
Usd Market Cap631003154.630-17%735129310.028780424104.626-6%881946920.104-17%1099361834.585-33%3149029169.044-77%
Usd Price Per Share0.419-17%0.4890.519-6%0.586-17%0.731-33%2.093-77%
Usd Profit---1584285.664-64823677.353+3992%2310198.097-169%-16625131.712+949%1697847.964-193%
Usd Revenue--280277996.415260178971.908+8%495497190.927-43%770203876.313-64%671773310.977-58%
Usd Total Gains Per Share--0.000-0.056+121433%-0.023+50774%-0.011+24798%0.023-100%
 EOD+3 -5MRQTTM+24 -11YOY+11 -245Y+17 -1810Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Shandong Realcan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-99.572
Price to Book Ratio (EOD)Between0-10.800
Net Profit Margin (MRQ)Greater than0-0.006
Operating Margin (MRQ)Greater than00.022
Quick Ratio (MRQ)Greater than10.493
Current Ratio (MRQ)Greater than11.055
Debt to Asset Ratio (MRQ)Less than10.673
Debt to Equity Ratio (MRQ)Less than12.139
Return on Equity (MRQ)Greater than0.15-0.002
Return on Assets (MRQ)Greater than0.05-0.001
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shandong Realcan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.554
Ma 20Greater thanMa 502.738
Ma 50Greater thanMa 1002.701
Ma 100Greater thanMa 2003.084
OpenGreater thanClose2.730
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Minority Interest  -5,267-2,635-7,901-922-8,8246,729-2,0954,4032,307



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets17,427,545
Total Liabilities11,731,513
Total Stockholder Equity5,483,431
 As reported
Total Liabilities 11,731,513
Total Stockholder Equity+ 5,483,431
Total Assets = 17,427,545

Assets

Total Assets17,427,545
Total Current Assets12,144,597
Long-term Assets5,282,948
Total Current Assets
Cash And Cash Equivalents 5,527,495
Short-term Investments 70,000
Net Receivables 5,604,462
Inventory 788,333
Other Current Assets 154,308
Total Current Assets  (as reported)12,144,597
Total Current Assets  (calculated)12,144,597
+/- 0
Long-term Assets
Property Plant Equipment 2,277,592
Goodwill 146,685
Intangible Assets 582,440
Other Assets 1,413,983
Long-term Assets  (as reported)5,282,948
Long-term Assets  (calculated)4,420,700
+/- 862,248

Liabilities & Shareholders' Equity

Total Current Liabilities11,516,622
Long-term Liabilities214,891
Total Stockholder Equity5,483,431
Total Current Liabilities
Short Long Term Debt 3,698,017
Accounts payable 7,059,996
Other Current Liabilities 730,964
Total Current Liabilities  (as reported)11,516,622
Total Current Liabilities  (calculated)11,488,977
+/- 27,645
Long-term Liabilities
Long term Debt 176,300
Capital Lease Obligations Min Short Term Debt1,062
Other Liabilities 37,529
Deferred Long Term Liability 71,013
Long-term Liabilities  (as reported)214,891
Long-term Liabilities  (calculated)285,905
+/- 71,013
Total Stockholder Equity
Common Stock1,504,710
Retained Earnings 452,338
Total Stockholder Equity (as reported)5,483,431
Total Stockholder Equity (calculated)1,957,049
+/- 3,526,382
Other
Capital Stock1,504,710
Common Stock Shares Outstanding 1,504,710
Net Invested Capital 9,357,748
Net Tangible Assets 4,754,306
Net Working Capital 627,976
Property Plant and Equipment Gross 2,277,592



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
> Total Assets 
715,530
1,039,963
1,479,478
1,495,935
2,130,615
2,198,794
2,217,545
2,617,744
2,656,917
3,070,133
3,120,369
3,543,587
3,623,226
3,947,583
4,454,233
4,748,939
4,981,474
5,128,745
5,678,332
6,718,386
7,395,600
7,936,514
8,861,694
10,285,889
11,040,490
15,309,929
15,656,826
18,245,833
20,161,813
23,347,502
26,983,016
29,116,724
33,117,257
34,742,518
34,836,043
36,951,073
37,598,017
37,234,036
32,465,274
34,177,693
33,207,954
33,370,461
31,290,194
32,364,586
29,479,890
28,865,141
26,396,974
27,523,652
25,783,946
23,789,369
18,331,075
19,189,860
18,281,210
17,427,545
17,427,54518,281,21019,189,86018,331,07523,789,36925,783,94627,523,65226,396,97428,865,14129,479,89032,364,58631,290,19433,370,46133,207,95434,177,69332,465,27437,234,03637,598,01736,951,07334,836,04334,742,51833,117,25729,116,72426,983,01623,347,50220,161,81318,245,83315,656,82615,309,92911,040,49010,285,8898,861,6947,936,5147,395,6006,718,3865,678,3325,128,7454,981,4744,748,9394,454,2333,947,5833,623,2263,543,5873,120,3693,070,1332,656,9172,617,7442,217,5452,198,7942,130,6151,495,9351,479,4781,039,963715,530
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,253,703
27,814,535
28,659,912
30,718,466
31,163,265
30,487,093
27,757,224
29,340,203
28,390,495
28,570,591
26,494,798
23,813,773
23,813,773
23,121,187
20,672,209
21,781,227
20,093,133
18,291,811
12,819,556
13,947,005
13,177,362
12,144,597
12,144,59713,177,36213,947,00512,819,55618,291,81120,093,13321,781,22720,672,20923,121,18723,813,77323,813,77326,494,79828,570,59128,390,49529,340,20327,757,22430,487,09331,163,26530,718,46628,659,91227,814,53526,253,70300000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,190,750
2,179,050
3,068,399
4,089,621
4,400,776
5,766,817
4,830,422
6,783,057
6,123,917
6,360,461
5,733,170
5,993,589
5,031,681
5,313,720
4,578,740
4,991,425
5,376,920
5,733,220
5,340,212
6,891,772
6,179,218
5,527,495
5,527,4956,179,2186,891,7725,340,2125,733,2205,376,9204,991,4254,578,7405,313,7205,031,6815,993,5895,733,1706,360,4616,123,9176,783,0574,830,4225,766,8174,400,7764,089,6213,068,3992,179,0502,190,75000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,830
0
0
0
198,090
201,620
97,744
94,265
40,790
6,230
9,130
9,100
0
0
0
10,000
0
100,000
120,000
70,000
70,000120,000100,000010,0000009,1009,1306,23040,79094,26597,744201,620198,09000077,8300000000000000000000000000000000000
       Net Receivables 
441,902
568,518
814,047
1,046,170
1,146,002
1,363,715
1,423,422
1,698,942
1,752,851
1,998,149
1,995,311
2,176,044
2,386,847
2,654,175
2,767,836
3,148,276
3,149,869
3,519,603
3,624,365
4,215,220
4,165,965
4,990,960
5,123,370
6,652,633
7,011,224
8,476,626
8,700,891
10,788,703
11,437,080
13,908,534
13,878,503
16,022,431
18,123,637
18,905,493
19,322,457
18,246,446
18,232,013
16,882,895
17,547,743
17,169,740
17,468,269
17,424,107
16,596,691
15,351,856
15,351,856
14,671,614
13,172,385
13,914,123
12,211,628
10,567,317
6,273,855
5,963,822
5,792,858
5,604,462
5,604,4625,792,8585,963,8226,273,85510,567,31712,211,62813,914,12313,172,38514,671,61415,351,85615,351,85616,596,69117,424,10717,468,26917,169,74017,547,74316,882,89518,232,01318,246,44619,322,45718,905,49318,123,63716,022,43113,878,50313,908,53411,437,08010,788,7038,700,8918,476,6267,011,2246,652,6335,123,3704,990,9604,165,9654,215,2203,624,3653,519,6033,149,8693,148,2762,767,8362,654,1752,386,8472,176,0441,995,3111,998,1491,752,8511,698,9421,423,4221,363,7151,146,0021,046,170814,047568,518441,902
       Other Current Assets 
29,408
25,220
30,557
55,343
76,861
104,521
66,753
117,276
131,182
233,950
109,101
195,196
183,928
211,945
61,165
179,819
153,818
95,791
135,391
164,054
147,135
150,067
126,130
191,192
241,260
332,857
392,356
500,525
639,333
828,899
1,199,725
1,527,246
1,700,228
2,042,209
1,670,494
127,934
159,861
167,296
1,444,178
1,608,131
1,591,526
1,670,893
1,185,664
1,011,119
1,011,119
951,393
853,146
990,453
786,062
576,455
250,974
222,340
205,991
154,308
154,308205,991222,340250,974576,455786,062990,453853,146951,3931,011,1191,011,1191,185,6641,670,8931,591,5261,608,1311,444,178167,296159,861127,9341,670,4942,042,2091,700,2281,527,2461,199,725828,899639,333500,525392,356332,857241,260191,192126,130150,067147,135164,054135,39195,791153,818179,81961,165211,945183,928195,196109,101233,950131,182117,27666,753104,52176,86155,34330,55725,22029,408
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,232,607
6,434,752
6,746,943
4,708,050
4,837,490
4,817,458
4,799,869
4,795,396
5,908,565
5,666,117
5,743,954
5,724,766
5,742,425
5,690,812
5,497,558
5,511,519
5,242,856
5,103,848
5,282,948
5,282,9485,103,8485,242,8565,511,5195,497,5585,690,8125,742,4255,724,7665,743,9545,666,1175,908,5654,795,3964,799,8694,817,4584,837,4904,708,0506,746,9436,434,7526,232,60700000000000000000000000000000000000
       Property Plant Equipment 
41,021
49,636
84,119
51,485
86,090
54,154
105,401
75,612
123,248
91,544
210,429
166,058
228,773
193,370
372,307
324,351
341,172
369,617
450,657
467,377
479,659
623,409
790,140
825,480
870,733
923,132
1,094,890
1,161,268
1,437,971
1,552,205
1,800,350
1,889,368
1,999,677
2,022,689
2,071,579
2,055,715
2,229,888
2,218,819
2,650,881
2,614,674
2,728,759
2,746,864
2,667,917
2,738,679
2,738,679
2,735,507
2,527,679
2,454,852
2,481,728
2,447,369
2,297,167
2,232,570
2,318,854
2,277,592
2,277,5922,318,8542,232,5702,297,1672,447,3692,481,7282,454,8522,527,6792,735,5072,738,6792,738,6792,667,9172,746,8642,728,7592,614,6742,650,8812,218,8192,229,8882,055,7152,071,5792,022,6891,999,6771,889,3681,800,3501,552,2051,437,9711,161,2681,094,890923,132870,733825,480790,140623,409479,659467,377450,657369,617341,172324,351372,307193,370228,773166,058210,42991,544123,24875,612105,40154,15486,09051,48584,11949,63641,021
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,093
28,596
28,596
55,535
60,055
82,665
244,087
463,629
679,072
983,941
1,388,865
1,508,665
1,975,320
2,217,105
3,050,712
3,757,057
3,932,582
4,310,146
4,427,707
3,308,410
3,313,703
3,298,281
3,119,162
1,263,915
1,250,410
857,800
847,822
804,507
804,507
705,823
703,608
620,267
620,267
591,184
515,650
146,685
146,685
146,685
146,685
146,685146,685146,685146,685515,650591,184620,267620,267703,608705,823804,507804,507847,822857,8001,250,4101,263,9153,119,1623,298,2813,313,7033,308,4104,427,7074,310,1463,932,5823,757,0573,050,7122,217,1051,975,3201,508,6651,388,865983,941679,072463,629244,08782,66560,05555,53528,59628,59630,093000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96,599
96,599
268,629
268,629
467,859
467,859
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000467,859467,859268,629268,62996,59996,59900000000000000000000000000000000
       Intangible Assets 
13,846
13,489
6,244
40,082
5,807
42,174
6,010
49,825
6,420
65,504
5,990
73,095
5,522
84,796
5,236
87,602
105,631
105,226
131,876
136,091
157,966
320,353
546,454
760,788
1,065,102
1,463,626
1,583,205
2,054,348
2,331,081
3,165,094
3,878,857
4,080,249
175,931
175,108
173,734
177,915
68,464
217,980
219,678
225,446
229,482
231,307
230,505
345,824
350,119
349,146
487,926
483,017
505,445
508,206
624,208
620,716
592,168
582,440
582,440592,168620,716624,208508,206505,445483,017487,926349,146350,119345,824230,505231,307229,482225,446219,678217,98068,464177,915173,734175,108175,9314,080,2493,878,8573,165,0942,331,0812,054,3481,583,2051,463,6261,065,102760,788546,454320,353157,966136,091131,876105,226105,63187,6025,23684,7965,52273,0955,99065,5046,42049,8256,01042,1745,80740,0826,24413,48913,846
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
442,358
243,824
551,813
164,899
286,039
129,715
2,867,418
82,220
155,278
98,675
95,429
390,542
402,444
359,227
359,516
1,028,498
849,174
663,932
633,787
633,787663,932849,1741,028,498359,516359,227402,444390,54295,42998,675155,27882,2202,867,418129,715286,039164,899551,813243,824442,35800000000000000000000000000000000000
> Total Liabilities 
603,640
805,780
1,183,445
1,184,895
1,366,167
1,410,786
1,400,437
1,777,074
1,804,436
2,187,387
2,203,981
2,587,509
2,647,970
2,925,826
2,804,245
3,059,069
3,257,966
3,369,481
3,853,031
3,674,192
4,289,158
4,708,047
5,457,341
6,553,387
7,126,421
8,083,164
8,154,173
10,248,450
11,725,642
14,384,242
17,308,705
18,996,139
22,224,498
23,435,709
23,530,052
25,331,119
25,864,091
25,336,190
22,212,527
23,665,770
22,755,288
22,778,129
20,810,455
21,801,529
19,430,938
18,801,517
16,703,818
17,946,274
16,169,318
15,231,435
12,579,268
13,399,987
12,490,390
11,731,513
11,731,51312,490,39013,399,98712,579,26815,231,43516,169,31817,946,27416,703,81818,801,51719,430,93821,801,52920,810,45522,778,12922,755,28823,665,77022,212,52725,336,19025,864,09125,331,11923,530,05223,435,70922,224,49818,996,13917,308,70514,384,24211,725,64210,248,4508,154,1738,083,1647,126,4216,553,3875,457,3414,708,0474,289,1583,674,1923,853,0313,369,4813,257,9663,059,0692,804,2452,925,8262,647,9702,587,5092,203,9812,187,3871,804,4361,777,0741,400,4371,410,7861,366,1671,184,8951,183,445805,780603,640
   > Total Current Liabilities 
603,640
805,780
1,183,445
1,184,895
1,366,167
1,410,786
1,400,437
1,777,074
1,804,436
2,187,387
2,203,981
2,584,725
2,647,970
2,925,826
2,804,245
3,059,069
3,257,967
3,369,481
3,853,031
3,674,192
4,289,159
4,708,047
5,457,341
6,553,387
7,126,421
8,083,164
8,154,173
10,248,450
11,627,556
14,187,549
15,618,149
17,310,065
19,582,387
20,906,606
21,273,719
23,251,647
23,766,952
23,242,804
20,660,093
22,085,904
22,481,586
22,515,159
20,563,363
19,199,683
19,199,683
18,529,715
16,507,784
17,726,932
16,007,859
15,085,318
12,468,437
13,331,769
12,332,944
11,516,622
11,516,62212,332,94413,331,76912,468,43715,085,31816,007,85917,726,93216,507,78418,529,71519,199,68319,199,68320,563,36322,515,15922,481,58622,085,90420,660,09323,242,80423,766,95223,251,64721,273,71920,906,60619,582,38717,310,06515,618,14914,187,54911,627,55610,248,4508,154,1738,083,1647,126,4216,553,3875,457,3414,708,0474,289,1593,674,1923,853,0313,369,4813,257,9673,059,0692,804,2452,925,8262,647,9702,584,7252,203,9812,187,3871,804,4361,777,0741,400,4371,410,7861,366,1671,184,8951,183,445805,780603,640
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,904
2,000
629,300
3,823,678
4,152,308
4,825,533
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004,825,5334,152,3083,823,678629,3002,000106,90400000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,904
2,000
629,300
3,823,678
4,152,308
4,825,533
5,192,357
6,154,594
5,847,051
5,860,799
9,514,031
8,818,987
7,893,384
6,928,682
4,165,027
4,908,470
5,675,265
5,478,591
3,839,835
5,482,137
4,238,555
3,698,017
3,698,0174,238,5555,482,1373,839,8355,478,5915,675,2654,908,4704,165,0276,928,6827,893,3848,818,9879,514,0315,860,7995,847,0516,154,5945,192,3574,825,5334,152,3083,823,678629,3002,000106,90400000000000000000000000000000000
       Accounts payable 
462,242
605,582
915,644
856,811
930,168
1,061,527
1,061,106
1,221,797
1,244,648
1,462,657
1,425,619
1,427,957
1,478,866
1,665,535
1,760,711
1,857,241
2,110,675
2,200,018
2,413,949
2,383,778
2,816,003
3,015,405
3,419,431
3,764,654
3,710,134
4,386,435
4,457,170
4,900,102
5,220,081
5,886,967
6,483,179
5,651,592
7,426,170
8,737,721
8,720,561
11,846,826
12,440,170
12,094,053
10,666,248
11,809,184
13,072,109
13,535,981
8,114,056
7,122,415
7,122,415
7,631,452
9,791,049
9,736,951
8,266,923
7,744,737
7,714,752
6,976,619
7,285,801
7,059,996
7,059,9967,285,8016,976,6197,714,7527,744,7378,266,9239,736,9519,791,0497,631,4527,122,4157,122,4158,114,05613,535,98113,072,10911,809,18410,666,24812,094,05312,440,17011,846,8268,720,5618,737,7217,426,1705,651,5926,483,1795,886,9675,220,0814,900,1024,457,1704,386,4353,710,1343,764,6543,419,4313,015,4052,816,0032,383,7782,413,9492,200,0182,110,6751,857,2411,760,7111,665,5351,478,8661,427,9571,425,6191,462,6571,244,6481,221,7971,061,1061,061,527930,168856,811915,644605,582462,242
       Other Current Liabilities 
31,398
20,198
11,732
21,876
23,359
26,236
21,831
26,613
31,124
124,730
138,362
347,895
454,204
376,906
130,821
97,717
85,030
117,703
166,335
114,674
149,656
218,642
454,160
912,852
1,222,267
1,937,203
1,774,468
2,688,270
2,808,670
4,413,854
5,471,707
5,594,966
5,447,618
8,486,098
5,445,549
1,927,560
1,217,943
300,000
4,180,072
4,011,813
2,553,918
2,626,040
1,931,503
2,402,738
2,402,738
2,632,257
2,479,526
3,039,130
1,666,401
1,640,999
882,873
778,335
669,595
730,964
730,964669,595778,335882,8731,640,9991,666,4013,039,1302,479,5262,632,2572,402,7382,402,7381,931,5032,626,0402,553,9184,011,8134,180,072300,0001,217,9431,927,5605,445,5498,486,0985,447,6185,594,9665,471,7074,413,8542,808,6702,688,2701,774,4681,937,2031,222,267912,852454,160218,642149,656114,674166,335117,70385,03097,717130,821376,906454,204347,895138,362124,73031,12426,61321,83126,23623,35921,87611,73220,19831,398
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,079,472
2,097,139
2,093,386
1,552,434
1,579,866
273,702
262,970
247,092
344,726
231,255
271,802
196,034
219,341
161,458
146,117
110,831
68,218
157,447
214,891
214,891157,44768,218110,831146,117161,458219,341196,034271,802231,255344,726247,092262,970273,7021,579,8661,552,4342,093,3862,097,1392,079,47200000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,186
11,614
23,356
22,374
21,476
21,402
180,885
180,812
177,798
177,605
225,950
223,359
224,126
230,270
238,729
171,140
171,140
168,959
108,340
108,307
54,338
43,330
40,901
40,290
38,601
37,529
37,52938,60140,29040,90143,33054,338108,307108,340168,959171,140171,140238,729230,270224,126223,359225,950177,605177,798180,812180,88521,40221,47622,37423,35611,6149,1860000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,877
56,761
63,936
80,798
87,822
94,087
81,438
99,338
130,352
108,543
148,712
144,366
144,366
143,280
134,584
141,911
119,977
125,525
89,932
89,162
78,677
71,013
71,01378,67789,16289,932125,525119,977141,911134,584143,280144,366144,366148,712108,543130,35299,33881,43894,08787,82280,79863,93656,76150,87700000000000000000000000000000000
> Total Stockholder Equity
111,889
233,916
296,034
311,040
764,449
786,073
815,184
838,739
852,492
882,760
916,409
946,821
965,922
1,004,801
1,631,688
1,671,602
1,710,629
1,746,108
1,797,890
3,027,467
3,078,343
3,122,646
3,194,403
3,322,743
3,430,642
6,657,251
6,875,616
7,167,652
7,327,187
7,521,765
7,805,968
8,036,073
8,336,147
8,486,842
8,451,390
8,621,654
8,676,644
8,872,219
7,186,493
7,282,091
7,396,793
7,495,212
7,469,056
7,514,307
7,558,238
7,568,268
7,567,036
7,395,415
7,435,712
6,964,058
5,407,788
5,437,030
5,488,920
5,483,431
5,483,4315,488,9205,437,0305,407,7886,964,0587,435,7127,395,4157,567,0367,568,2687,558,2387,514,3077,469,0567,495,2127,396,7937,282,0917,186,4938,872,2198,676,6448,621,6548,451,3908,486,8428,336,1478,036,0737,805,9687,521,7657,327,1877,167,6526,875,6166,657,2513,430,6423,322,7433,194,4033,122,6463,078,3433,027,4671,797,8901,746,1081,710,6291,671,6021,631,6881,004,801965,922946,821916,409882,760852,492838,739815,184786,073764,449311,040296,034233,916111,889
   Common Stock
50,000
70,000
70,000
70,000
93,800
93,800
93,800
93,800
93,800
93,800
93,800
93,800
93,800
93,800
108,948
108,948
108,948
217,895
217,895
277,272
277,272
554,544
554,544
554,544
554,544
654,222
654,222
654,222
1,504,711
1,504,711
1,504,711
1,504,711
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,710
1,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7101,504,7111,504,7111,504,7111,504,711654,222654,222654,222554,544554,544554,544554,544277,272277,272217,895217,895108,948108,948108,94893,80093,80093,80093,80093,80093,80093,80093,80093,80093,80070,00070,00070,00050,000
   Retained Earnings 
41,300
10,834
66,957
81,963
100,279
121,903
143,092
166,647
180,447
210,715
235,258
265,671
284,771
323,650
356,678
431,636
470,663
506,142
558,001
608,987
661,283
705,586
775,640
861,100
968,999
1,124,188
1,342,553
1,634,589
1,797,140
2,005,309
2,291,231
2,571,521
2,871,596
3,022,290
2,967,568
3,026,396
3,161,401
3,356,976
1,961,951
2,057,557
2,172,252
2,270,671
2,227,095
2,264,710
2,264,710
2,274,648
2,278,039
2,320,776
2,337,030
2,325,855
433,118
454,278
463,786
452,338
452,338463,786454,278433,1182,325,8552,337,0302,320,7762,278,0392,274,6482,264,7102,264,7102,227,0952,270,6712,172,2522,057,5571,961,9513,356,9763,161,4013,026,3962,967,5683,022,2902,871,5962,571,5212,291,2312,005,3091,797,1401,634,5891,342,5531,124,188968,999861,100775,640705,586661,283608,987558,001506,142470,663431,636356,678323,650284,771265,671235,258210,715180,447166,647143,092121,903100,27981,96366,95710,83441,300
   Capital Surplus 000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,519,623
Cost of Revenue-6,858,877
Gross Profit660,747660,747
 
Operating Income (+$)
Gross Profit660,747
Operating Expense-7,838,350
Operating Income-318,726-7,177,603
 
Operating Expense (+$)
Research Development22,495
Selling General Administrative524,192
Selling And Marketing Expenses-
Operating Expense7,838,350546,688
 
Net Interest Income (+$)
Interest Income84,668
Interest Expense-313,408
Other Finance Cost-17,973
Net Interest Income-246,713
 
Pretax Income (+$)
Operating Income-318,726
Net Interest Income-246,713
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,895,075-318,726
EBIT - interestExpense = -313,408
-1,873,517
-1,560,109
Interest Expense313,408
Earnings Before Interest and Taxes (EBIT)--1,581,667
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,895,075
Tax Provision--38,071
Net Income From Continuing Ops-1,857,003-1,857,003
Net Income-1,873,517
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-246,713
 

Technical Analysis of Realcan
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Realcan. The general trend of Realcan is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Realcan's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shandong Realcan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.16 < 3.16 < 3.19.

The bearish price targets are: 3.01 > 2.94 > 2.51.

Tweet this
Shandong Realcan Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shandong Realcan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shandong Realcan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shandong Realcan Pharmaceutical Co Ltd. The current macd is 0.04662914.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Realcan price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Realcan. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Realcan price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShandong Realcan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shandong Realcan Pharmaceutical Co Ltd. The current adx is 23.19.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Realcan shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shandong Realcan Pharmaceutical Co Ltd. The current sar is 2.69.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shandong Realcan Pharmaceutical Co Ltd. The current rsi is 64.55. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShandong Realcan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shandong Realcan Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Realcan price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShandong Realcan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shandong Realcan Pharmaceutical Co Ltd. The current cci is 147.32.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShandong Realcan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shandong Realcan Pharmaceutical Co Ltd. The current cmo is 39.49.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShandong Realcan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shandong Realcan Pharmaceutical Co Ltd. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Shandong Realcan Pharmaceutical Co Ltd Daily Williams %R ChartShandong Realcan Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shandong Realcan Pharmaceutical Co Ltd.

Shandong Realcan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shandong Realcan Pharmaceutical Co Ltd. The current atr is 0.12075284.

Shandong Realcan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShandong Realcan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shandong Realcan Pharmaceutical Co Ltd. The current obv is 362,631,403.

Shandong Realcan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShandong Realcan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shandong Realcan Pharmaceutical Co Ltd. The current mfi is 67.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shandong Realcan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShandong Realcan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shandong Realcan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Shandong Realcan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shandong Realcan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.554
Ma 20Greater thanMa 502.738
Ma 50Greater thanMa 1002.701
Ma 100Greater thanMa 2003.084
OpenGreater thanClose2.730
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Realcan with someone you think should read this too:
  • Are you bullish or bearish on Realcan? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Realcan? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shandong Realcan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shandong Realcan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shandong Realcan Pharmaceutical Co Ltd.

Receive notifications about Shandong Realcan Pharmaceutical Co Ltd in your mailbox!